RAC 2.20% $1.78 race oncology ltd

Ann: Zantrene Protects Mouse Hearts from Chemotherapy Damage, page-17

  1. 96 Posts.
    lightbulb Created with Sketch. 62
    The most exciting thing for me about this announcement is the fact that there is data from this work which they are not showing because it is too good.

    Its "of the highest scientific and clinical interest"

    Don't you just love to speculate what this could be?!

    If these results are published in a high impact peer reviewed journal it will immediately bring important global recognition and interest to Zantrene.

    I will be eagerly away the publication of these results later this year as major milestone in the story of this company.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.